Obesity News

Medindia's Press Release’ section provides the latest press release on Obesity from across the world for the global audience. This page links to 441 Obesity press releases.

Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

CAMBRIDGE, Mass. , March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today ...


Obesity Action Coalition (OAC) Mobilizes Advocates on Capitol Hill to Mark the Start of Obesity Care Week 2024

WASHINGTON , March 1, 2024 /PRNewswire/ -- To kick off Obesity Care Week 2024, more than 60 advocates with the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with more than 70 legislators to express the importance of ...

NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

First Patient Expected to be Randomized in the Second Quarter of 2024 CAMBRIDGE, Mass. , Feb. 29, 2024 /PRNewswire/ --  NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on ...

NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

Preclinical Studies Show DA-1726 Elicits Superior Weight Loss Compared to Semaglutide (Wegovy™) and Similar Weight Loss Compared to Tirzepatide (Mounjaro™), While Consuming More Food Initiation of Phase 1 Clinical Trial Expected to Occur ...

NeuroBo Pharmaceuticals Submits IND Application to the FDA for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

CAMBRIDGE, Mass. , Dec. 28, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has submitted an ...

Doctors and Advocates Call for Better Testing and Labeling of Drugs for People with Obesity

TAMPA, Fla. , Nov. 28, 2023 /PRNewswire/ -- The Obesity Action Coalition (OAC) announces the publication of a "Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity." The ...

With Obesity on the Rise, New Bariatric Study Finds Surgeons Don't Follow the Same Best Practices, Even Within the Same Hospital

With over 100 million US adults experiencing obesity, and the condition accounting for $173 billion dollars in extra health costs annually, health tech company Theator set out to examine how bariatric surgeries are stacking up, only to find ...

Innovent Announces Robust Weight Loss Efficacy, Multiple Metabolic Benefits and Favorable Safety Profile of Higher Dose 9 mg Mazdutide (IBI362) after 48-week Treatment in Phase 2 Study for Obesity

Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic indicators (waist circumferenc e, ...

Federal Officials and Local Leaders to Discuss Policy Solutions to Nation's Obesity Crisis

WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Live-stream and In Person Event, October 11 , 2:00 – 4:00 PM, ET National Press Club, Washington DC , or live stream – register here: The State of Obesity: Creating Pathways to a ...

Foresee Pharmaceuticals Announces Publication of Preclinical Data in Nature Communications Demonstrating the Therapeutic Potential of ALDH2 Activator AD-9308 in the Treatment of Obesity and Metabolic Syndrome-Related Disorders

AD-9308 is a potent, and highly selective oral ALDH2 activator ready for IND-enabling development. AD-9308 treatment ameliorates diet-induced obesity and fatty liver, and improves glucose homeostasis in both male Aldh2 wild-type and Aldh2 ...

Obesity News »

Rising Tide of Obesity Among Indian Kids Sparks Concern

Rising Tide of Obesity Among Indian Kids Sparks Concern

Doctors state that childhood obesity in India has surged significantly, leading to an unhealthy future for these children . World Obesity Day ( ) is observed every year on March 4 to raise awareness about the condition and its implications.“As a consultant ...

Obesity, Smoking & Poor Exercise Spurs Blood Cancer Risk

Obesity, Smoking & Poor Exercise Spurs Blood Cancer Risk

Obesity , smoking , and low levels of physical exercise increase the risk of monoclonal gammopathy of unknown significance (MGUS), a benign blood disorder that frequently precedes multiple myeloma, according to a new study published in Blood ...

Indian-Origin Engineer's Weapon Against Obesity

Indian-Origin Engineer's Weapon Against Obesity

New vibrating and ingestible capsule , developed by an Indian-origin engineer at the Massachusetts Institute of Technology (MIT), has the potential to create a feeling of fullness, deceiving the brain into perceiving meal completion, offering a ...

Intermittent Energy Restriction and the Lasting Weight Loss Symphony

Intermittent Energy Restriction and the Lasting Weight Loss Symphony

In tackling obesity worldwide , intermittent energy restriction (IER) triggers coordinated shifts in the brain-gut microbiome axis, thereby presenting a promising approach to weight loss for over one billion obese individuals ( ). ...

Obesity Drug Set to Exceed Ozempic With $27 Billion Sales by 2029

Obesity Drug Set to Exceed Ozempic With $27 Billion Sales by 2029

Eli Lilly's Mounjaro is positioned to outpace Novo Nordisk's Ozempic (semaglutide) and claim the top spot in sales within the obesity and diabetes market....

More Obesity News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.